We have previously shown that platelet ADP receptors are coupled to G-proteins On the basis of agonist selectivity and signalling properties
INTRODUCTION
Platelet aggregation by ADP plays a key role in the development and extension of arterial thrombosis. Stored at very high concentrations in platelet dense granules, ADP is released when platelets are stimulated by other aggregating agents, such as thrombin or collagen, and so contributes to and reinforces platelet aggregation. In addition, ADP at low concentrations potentiates or amplifies the effects of all other stimuli, even weak agonists such as adrenaline or serotonin [1] [2] [3] . Addition of ADP to washed human platelet suspensions results in shape change, exposure of the fibrinogen-binding site on the aIIb b. 3 integrin and reversible aggregation in the presence of fibrinogen and physiological concentrations of Ca2l. At the intracellular level, platelet activation following ADP binding to its receptor leads to a transient rise in free cytoplasmic Ca2+, resulting from both Ca2+ influx and mobilization of internal stores. ADP also inhibits stimulated adenylyl cyclase [1] , but this is not causally involved in platelet aggregation.
On the basis of agonist selectivity and signalling properties [4, 5] , the platelet receptor for ADP has been classified as a P2T
receptor of the P2 purinoceptor family. Its main characteristic is that ADP is its natural agonist while ATP is a competitive antagonist. However the biochemical structure of this receptor remains unknown. Most of the platelet membrane receptors such as platelet-activating factor, thromboxane A2 (TXA2), thrombin, adrenaline and 5'-hydroxytryptamine belong to the seven transmembrane domain G-protein-coupled receptor family, and many have been cloned and sequenced [6] . Several ADP-binding proteins have been proposed as putative ADP receptors, for instance the 100 kDa protein called aggregin [7] or more recently a 40 kDa protein which incorporates a photoaffinity analogue of ADP [8] . deferens and pheochrocytoma PC12 cells [9] . Whether the P2T receptor is a G-protein-coupled or a channel-linked receptor is not known. It has been proposed that there could exist more than one type of ADP receptor in blood platelets, since the ADPbinding protein seems to possess characteristics of both known types [3] . In contrast to the other P2 purinoceptors, which are broadly expressed in many tissues, the P2T receptor(s) appears to be specific for platelets and has never been found in other cells, apart from certain studies where functional properties. suggested that this receptor could be expressed by K562 [10] and Dami leukaemia cells [11] , or where functional and binding characteristics indicated its presence in the megakaryoblastic cell line Meg-01 [12] . Obviously, a better knowledge of the ADP plateletactivation pathway is of major importance for the identification of this receptor and the understanding of the physiology of primary haemostasis. We [13, 14] , suggesting that the ADP receptor is coupled to G-proteins, the nature of which remain to be identified. The aim of the present study was the identification of these activated G-proteins. For 
Antibodies
Rabbit polyclonal antibodies were raised against peptides corresponding to specific regions of G-protein a-subunits and coupled to keyhole limpet haemocyanin (KLH) with an additional cysteine at the N-terminus as previously described [16] . The antisera were designated as follows: AS 8 (anti-a common);
AS 190 (anti-ail); AS 269 (anti-ai2); AS 105 (anti-ac3); AS 266 (anti-a13); AS 266 (anti-ai common); AS 227 (anti-cc,); AS 369 (anti-a9g11); AS 232 (anti-al2); and AS 343 (anti-al3). All were of known characteristics [15, 17, 18] and were employed as crude sera for immunoprecipitation and immunoblotting.
Platelet membrane preparation Human platelets were isolated and washed as previously described [19] , and resuspended in Tyrode's buffer, without Ca2 , containing 2 mM EDTA, apyrase (2 ,ug/ml) and protease
The platelet suspension was frozen and thawed before being homogenized in a glass-Teflon homogenizer on ice. Membranes were pelleted by centrifugation (30000 g for 15 min) at + 4°C and the final pellet was resuspended in 50 mM Tris/HCl (pH 7.5) containing 2 mM EDTA and stored at -80 'C. Protein concentrations were determined with the bicinchoninic acid (BCA) protein assay system (Pierce, Rockford, IL, USA immunoblotting Platelet membrane proteins were separated on 9 % polyacrylamide gels containing 6 M urea for the Gcci subunits and on 13 % polyacrylamide gels without urea for members of the Gaq,11 and Gac12 families. Immunodetection of Gac subunits was performed by the enhanced chemiluminescence (ECL) procedure (Amersham, Little Chalfont, U.K.) as described in [17] .
Reproducibility
The experiments shown are representative of at least three independent assays using different membrane preparations.
RESULTS Immunoblotting
Immunoblotting of platelet membranes with antisera raised against peptides corresponding to specific regions of G-protein a-subunits (see Table 1 ) confirmed that platelets express G1-, Gq-and G12-proteins [17] , with the exception of Gai, which was not recognized by our antibody (Figure 1 ). [17] , U46619 stimulated the photolabelling of Gaq, Gai2
( Figure 2 ) and Ga13 proteins (results not shown) without any effect on Gac, where TRAP-SF7 stimulated Gac, Gccq and Ga12 Figure 3 Photolabelling of Goa1 subtypes under ADP and thrombin receptor stimulation Membranes (400 ,ug) were incubated in a medium containing 10 ,cM GDP and photolabelled as described in Figure 2 in the absence of a stimulator (control) or in the presence of 10 ,uM ADP, 10 uM TRAP-SF7 or 5 ,uM U46619 (negative control). The samples were then solubilized in a medium containing 1% (w/v) Chaps instead of NP40. Proteins were immunoprecipitated with antisera As 269 (anti-ac2, 20,lu) and AS 105 (anti-ac3, 20,u), separated on SDS/10% acrylamide gels and revealed by autoradiography of the dried gels. subtype-specific antisera, we observed that ADP stimulated the photolabelling of Gai2but not of Gac3, while TRAP-SF7 stimulated the labelling of both Gai2 and Gai3, (Figure 3 ). In Gai subtype-specific immunoprecipitation experiments, the platelet membranes were solubilized with Chaps instead of NP40, which improved the immunoprecipitation of Gac2 and Gai3 with our antibodies. The stimulatory effect of ADP was concentration dependent from 0.1-10 M and was inhibited by simultaneous incubation with the P2T receptor antagonist ATP (10 ,M) . This is illustrated in Figure 4 , where Figure 4 (a) shows an autoradiogram of a dried gel and Figure 4( [13, 14] , suggesting that the ADP receptor is coupled to Gproteins, the nature of which remain unknown. In order to identify these proteins, we combined photolabelling of receptoractivated G-proteins with immunoprecipitation of the labelled G-protein a-subunits. This method allows exact identification of the receptor-activated G-proteins, provided the necessary subtype-specific antisera are available [15] . All the antibodies used recognized the corresponding G-protein a-subunit in platelets except the anti-Gacil AS 190 antibody. This antibody recognizes Gail in the human neuroblastoma cell line SH-SY5Y [18] and purified Gail from bovine brain [23] . thrombin activated both Gaq and Ga. [17] . U46619 activates phospholipase C (PLC) in a pertussis toxin independent manner through Gq. Thrombin or the thrombin receptor agonist peptide (TRAP-SF7) simultaneously inhibits adenylyl cyclase through Gi proteins and activates phospholipase C (PLC) through Gq and presumably by means of fly dimers of pertussis toxin sensitive G-proteins [6] . Whereas ADP is known to inhibit platelet adenylyl cyclase, it is a matter of debate whether or not this agonist causes activation of PLC [3] . Our results support the idea that ADP does not activate PLC through the Gq pathway.
On the other hand, adrenaline, which is not itself an aggregating agent [25] , has been shown to inhibit adenylyl cyclase in human platelets through a2 adrenergic receptors which are coupled to Gai2 [26] , without causing any change in cytoplasmic Ca2+ levels. D-myo-inositol 1,4,5-triphosphate, the signal transduction pathways of ADP are poorly understood [3] . ADP induces an increase in intracellular Ca2+ in a unique manner, involving both activation of non-selective cation channels [27] and mobilization of internal stores by a still unidentified pathway. Studies of the mechanism of action of the anti-thrombotic drugs ticlopidine and clophidogrel, which are specific inhibitors of ADP-induced platelet aggregation [28] , have shown that in the case of rat platelets, the inhibition of the increase in intracellular Ca2l is due to blockade of the mobilization of internal stores [29] . Although we did not find the same effect in human volunteers [30] , this discrepancy could arise from the fact that the doses of drugs given to the animals were very much higher than those permissible in humans. These drugs do inhibit the ADP receptor-induced activation of G-proteins [14] . However, whether the Ca2+-mobilizing effect of ADP receptor stimulation is a G-proteindependent effect remains to be established. Studies of patients with selective deficiency of ADP-induced platelet aggregation [31] [32] , who have reduced numbers of binding sites for 2MeSADP, a specific P2T agonist, should be of interest in this respect, and we are currently investigating such a patient with our system [33] .
CONCLUSIONS
Our results confirm that ADP-induced platelet activation is partly due to a G-protein-coupled receptor, which interacts with the Gax2 heterotrimeric G-protein. This may explain how ADP inhibits adenylyl cyclase. On the other hand, the absence of activation of the Gq pathway raises the question of the mechanism of Ca2+ mobilization and the subsequent aggregation process for which, as in case of adrenaline, inhibition of adenylyl cyclase is not sufficient.
